Targeted inhibition of m6A demethylase FTO by FB23 attenuates allergic inflammation in the airway epithelium
The FASEB Journal · 15.08.2024 · 38 (15)
DOI: 10.1096/fj.202400545r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 02.08.2024. Verfasst von Zexuan Lian und 17 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Gua…. Hauptthemen laut MEDLINE: Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Asthma, Inflammation. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: Guangdong Basic and Applied Basic Research Foundation, Major Project of Guangzhou National Laboratory, Guangdong Provincial Department of Education.
Abstract (Originalsprache)
Epithelial cells play a crucial role in asthma, contributing to chronic inflammation and airway hyperresponsiveness. m6A modification, which involves key proteins such as the demethylase fat mass and obesity‐associated protein (FTO), is crucial in the regulation of various diseases, including asthma. However, the role of FTO in epithelial cells and the development of asthma remains unclear. In this study, we investigated the demethylase activity of FTO using a small‐molecule inhibitor FB23 in epithelial cells and allergic inflammation in vivo and in vitro. We examined the FTO‐regulated transcriptome‐wide m6A profiling by methylated RNA immunoprecipitation sequencing (MeRIP‐seq) and RNA‐seq under FB23 treatment and allergic inflammation conditions. Immunofluorescence staining was performed to assess the tissue‐specific expression of FTO in asthmatic bronchial mucosa. We demonstrated that FB23 alleviated allergic inflammation in IL‐4/IL‐13‐treated epithelial cells and house dust mite (HDM)‐induced allergic airway inflammation mouse model. The demethylase activity of FTO contributed to the regulation of TNF‐α signaling via NF‐κB and epithelial–mesenchymal transition‐related pathways under allergic inflammation conditions in epithelial cells. FTO was expressed in epithelial, submucosal gland, and smooth muscle cells in human bronchial mucosa. In conclusion, FB23‐induced inhibition of FTO alleviates allergic inflammation in epithelial cells and HDM‐induced mice, potentially through diverse cellular processes and epithelial–mesenchymal transition signaling pathways, suggesting that FTO is a potential therapeutic target in asthma management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangdong Provincial Key Laboratory of Allergy & Clinical Immunology, Dep…
- State Key Laboratory of Respiratory Disease Allergy Division at Shenzhen University, Shenzhen Key Laboratory of Allergy and Immunology, Shenzhen University, Shenzhen, Guangdong, P.R. China.
- State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital,…
- GMU-GIBH Joint School of Life Sciences, The Guangdong-Hong Kong-Macau Joint Laboratory for Cell Fate Regulation and Diseases, Guangzhou National Laboratory, Guangzhou Medical University, Guangzhou, P.R. China.
ORCID-Profile: Zexuan Lian, Ruchong Chen, Mo Xian, Peiying Huang, Jiahan Xu, Xiaojun Xiao, Xiaoping Ning, Jin Zhao, Jianlei Xie, Jielin Duan, Bizhou Li, Wanjun Wang, Xu Shi, Xinru Wang, Nan Jia, Xuepeng Chen, Jing Li, Zhaowei Yang
Förderung
- Guangdong Basic and Applied Basic Research Foundation
- Major Project of Guangzhou National Laboratory
- Guangdong Provincial Department of Education
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Lian, Z., Chen, R., Xian, M., Huang, P., Xu, J., Xiao, X., Ning, X., Zhao, J., Xie, J., Duan, J., Li, B., Wang, W., Shi, X., Wang, X., Jia, N., Chen, X., Li, J., & Yang, Z. (2024). Targeted inhibition of m6A demethylase FTO by FB23 attenuates allergic inflammation in the airway epithelium. The FASEB Journal, 38(15). https://doi.org/10.1096/fj.202400545r
Vancouver
Lian Z, Chen R, Xian M, Huang P, Xu J, Xiao X, et al. Targeted inhibition of m6A demethylase FTO by FB23 attenuates allergic inflammation in the airway epithelium. The FASEB Journal. 2024;38(15). doi:10.1096/fj.202400545r
BibTeX
@article{Lian2024,
author = {Lian, Zexuan and Chen, Ruchong and Xian, Mo and Huang, Peiying and Xu, Jiahan and Xiao, Xiaojun and Ning, Xiaoping and Zhao, Jin and Xie, Jianlei and Duan, Jielin and Li, Bizhou and Wang, Wanjun and Shi, Xu and Wang, Xinru and Jia, Nan and Chen, Xuepeng and Li, Jing and Yang, Zhaowei},
title = {Targeted inhibition of m6A demethylase FTO by FB23 attenuates allergic inflammation in the airway epithelium},
journal = {The FASEB Journal},
year = {2024},
volume = {38},
number = {15},
doi = {10.1096/fj.202400545r}
}
EUVIMED